Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 697

1.

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.

Tashiro M, McKimm-Breschkin JL, Saito T, Klimov A, Macken C, Zambon M, Hayden FG; Neuraminidase Inhibitor Susceptibility Network.

Antivir Ther. 2009;14(6):751-61. doi: 10.3851/IMP1194.

PMID:
19812437
2.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

3.

Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.

Dapat C, Kondo H, Dapat IC, Baranovich T, Suzuki Y, Shobugawa Y, Saito K, Saito R, Suzuki H.

Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.

PMID:
23791870
4.

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.

Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H; Japanese Influenza Collaborative Study Group.

J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.

PMID:
19962344
5.

Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.

Abed Y, Nehmé B, Baz M, Boivin G.

Antiviral Res. 2008 Feb;77(2):163-6. Epub 2007 Sep 10.

PMID:
17919743
6.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

PMID:
19911968
7.

Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.

Bauer K, Richter M, Wutzler P, Schmidtke M.

Antiviral Res. 2009 Apr;82(1):34-41. doi: 10.1016/j.antiviral.2009.01.006. Epub 2009 Feb 6.

PMID:
19428593
8.

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.

Okomo-Adhiambo M, Sleeman K, Lysén C, Nguyen HT, Xu X, Li Y, Klimov AI, Gubareva LV.

Influenza Other Respir Viruses. 2013 Sep;7(5):645-58. doi: 10.1111/irv.12113. Epub 2013 Apr 10.

9.

Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.

Zürcher T, Yates PJ, Daly J, Sahasrabudhe A, Walters M, Dash L, Tisdale M, McKimm-Breschkin JL.

J Antimicrob Chemother. 2006 Oct;58(4):723-32. Epub 2006 Aug 5.

PMID:
16891631
10.

Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.

Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, Lina B, Morfin F, Ferraris O.

J Clin Virol. 2008 Jan;41(1):25-8. Epub 2007 Dec 4.

PMID:
18055253
12.

A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.

Duwe S, Schweiger B.

J Virol Methods. 2008 Nov;153(2):134-41. doi: 10.1016/j.jviromet.2008.07.017. Epub 2008 Sep 19.

PMID:
18725246
13.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
14.

Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.

Zaraket H, Saito R, Wakim R, Tabet C, Medlej F, Reda M, Baranovich T, Suzuki Y, Dapat C, Caperig-Dapat I, Dbaibo GS, Suzuki H.

J Med Virol. 2010 Jul;82(7):1224-8. doi: 10.1002/jmv.21795.

PMID:
20513088
15.

Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.

Bauer K, Dürrwald R, Schlegel M, Pfarr K, Topf D, Wiesener N, Dahse HM, Wutzler P, Schmidtke M.

Med Microbiol Immunol. 2012 Feb;201(1):61-72. doi: 10.1007/s00430-011-0206-1. Epub 2011 Jun 19.

PMID:
21688167
16.
17.

Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.

Jonges M, van der Lubben IM, Dijkstra F, Verhoef L, Koopmans M, Meijer A.

Antiviral Res. 2009 Sep;83(3):290-7. doi: 10.1016/j.antiviral.2009.07.003. Epub 2009 Jul 8.

PMID:
19591877
18.

Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.

Pontoriero A, Baumeister E, Campos AM, Savy VL.

Rev Panam Salud Publica. 2011 Dec;30(6):634-40.

19.

Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season.

Ciblak MA, Hasoksuz M, Escuret V, Valette M, Gul F, Yilmaz H, Turan N, Bozkaya E, Badur S.

J Med Virol. 2009 Sep;81(9):1645-51. doi: 10.1002/jmv.21546.

PMID:
19626608
20.

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.

Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):381-8. doi: 10.1016/j.antiviral.2009.11.005. Epub 2009 Nov 13.

PMID:
19917319

Supplemental Content

Support Center